Studies on the Effect of Oral and Parenteral Administration of Visammin (Khellin) in Patients with Angina Pectoris-Reference-Cited by-同舟云学术

Studies on the Effect of Oral and Parenteral Administration of Visammin (Khellin) in Patients with Angina Pectoris

Published:1951-01 Issue:1 Volume:3 Page:80-88
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

SCOTT RALPH C.¹,IGLAUER ARNOLD¹,GREEN ROBERT S.¹,KAUFMAN JOSEPH W.¹,BERMAN BERNARD¹,MCGUIRE JOHNSON¹

Affiliation:

1. From the Cardiac Laboratory, Department of Internal Medicine, College of Medicine, University of Cincinnati and the Cincinnati General Hospital, Cincinnati, Ohio.

Abstract

Of 20 carefully studied patients with angina pectoris given oral visammin, 4 had a significant reduction in number of pains. Eleven stated that their pains were less severe and less easily precipitated while taking visammin. There was questionable improvement in the exercise tolerance test in 2 of 9 patients after oral visammin therapy. The daily oral dose ranged from 40 mg. to 240 mg. Undesirable side effects were encountered in 17 of the 20 patients. Parenteral administration of visammin was evaluated by means of the ballistocardiograph, the exercise tolerance test, and by tilting.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.3.1.80

Reference24 articles.

1. Visammin as generic designation for dimethoxYmethyl-furano-chromone;J. A. M. A.,1949

2. AMMI VISNAGA IN THE TREATMENT OF THE ANGINAL SYNDROME

3. Comparative pharmacology of khellin;KILLAMI K. F.;Federation Proc.,1950

4. The coronary vasodilator action of khellin

5. KHELLIN IN ANGINA PECTORIS

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self‐Emulsifying Drug Delivery of Khellin for Improving Its Oral Bioavailability;ChemistrySelect;2023-12-06

2. Thermodynamic solubility determination of khellin in eight mono-solvents at the range of 298.15 to 323.15 K;Journal of Molecular Liquids;2022-04

3. Enhancing Biopharmaceutical Attributes of Khellin by Amorphous Binary Solid Dispersions;AAPS PharmSciTech;2021-10-27

4. Khellin and Visnagin Differentially Modulate AHR Signaling and Downstream CYP1A Activity in Human Liver Cells;PLoS ONE;2013-09-19

5. Bibliography;Coronary Vasodilators;1961